TARGET ONCOL 润色咨询

Targeted Oncology

出版年份：2006 年文章数：444 投稿命中率： 开通期刊会员，数据随心看

出版周期：Quarterly 自引率：1.6% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=563459, encodeId=6a6e5634592b, content=我的和您一样，他们推荐的杂志都是sci收录的吗<span class="quote">灬赫梦灬 2018-10-06 00:00:00 发表:<br>投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）</span>, beContent=灬赫梦灬 2018-10-06 00:00:00 发表: 投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er3UxGicC980EKc92ndV1cBYEGDyd0wziapVJ0KcPnu0S3QxngVtCgGIt9ehOm7sibVgcKOPIq7tsx6A/132, createdBy=2838104137, createdName=joemarton, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563026, encodeId=777356302671, content=请问需要审稿费吗spanclassquote灬赫梦灬20181006发表br审稿时间约1个月投了一篇文章审稿非常效率3天后就回复了说是文章不在这个期刊的范围内原文TargetedOncologyfocusesonthedevelopmentanduseofmolecularlytargetedagentsinoncologyYourcurrentsubmissionisthereforeoutsidethescopeofthejournal推荐我使用TheSpringerTransferDeskservice推荐给我合适的期刊已同意等待回复期刊列表中我会持续更新最新动态给以后大家的投稿提供经验吧勿喷谢谢span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0e71947222, createdName=1e105fc2m38(暂无匿称), createdTime=Fri Nov 09 22:16:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562475, encodeId=951e5624e547, content=请问需要多少版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed852076992, createdName=Aaaaaaaaa6010, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561560, encodeId=e68056156011, content=季刊<span class="quote">灬赫梦灬 2018-09-25 00:00:00 发表:<br>请问这个杂志是月刊还是季刊</span>, beContent=灬赫梦灬 2018-09-25 00:00:00 发表: 请问这个杂志是月刊还是季刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6a12344708, createdName=1229ae0cm53(暂无昵称), createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561439, encodeId=47ee56143954, content=请问这个杂志是月刊还是季刊<span class="quote">183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表:<br>好杂志.效率高</span>, beContent=183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表: 好杂志.效率高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/06/65b1c2edc15a8f02bc91102330953561.jpg, createdBy=c7ab2448888, createdName=灬赫梦灬, createdTime=Tue Sep 25 00:00:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558496, encodeId=85d255849699, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志.效率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6a12344708, createdName=1229ae0cm53(暂无昵称), createdTime=Wed Jun 27 15:09:00 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-11-21 joemarton

    我的和您一样，他们推荐的杂志都是sci收录的吗灬赫梦灬 2018-10-06 00:00:00 发表:
    投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）

    灬赫梦灬 2018-10-06 00:00:00 发表: 投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=563459, encodeId=6a6e5634592b, content=我的和您一样，他们推荐的杂志都是sci收录的吗<span class="quote">灬赫梦灬 2018-10-06 00:00:00 发表:<br>投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）</span>, beContent=灬赫梦灬 2018-10-06 00:00:00 发表: 投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er3UxGicC980EKc92ndV1cBYEGDyd0wziapVJ0KcPnu0S3QxngVtCgGIt9ehOm7sibVgcKOPIq7tsx6A/132, createdBy=2838104137, createdName=joemarton, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563026, encodeId=777356302671, content=请问需要审稿费吗spanclassquote灬赫梦灬20181006发表br审稿时间约1个月投了一篇文章审稿非常效率3天后就回复了说是文章不在这个期刊的范围内原文TargetedOncologyfocusesonthedevelopmentanduseofmolecularlytargetedagentsinoncologyYourcurrentsubmissionisthereforeoutsidethescopeofthejournal推荐我使用TheSpringerTransferDeskservice推荐给我合适的期刊已同意等待回复期刊列表中我会持续更新最新动态给以后大家的投稿提供经验吧勿喷谢谢span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0e71947222, createdName=1e105fc2m38(暂无匿称), createdTime=Fri Nov 09 22:16:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562475, encodeId=951e5624e547, content=请问需要多少版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed852076992, createdName=Aaaaaaaaa6010, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561560, encodeId=e68056156011, content=季刊<span class="quote">灬赫梦灬 2018-09-25 00:00:00 发表:<br>请问这个杂志是月刊还是季刊</span>, beContent=灬赫梦灬 2018-09-25 00:00:00 发表: 请问这个杂志是月刊还是季刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6a12344708, createdName=1229ae0cm53(暂无昵称), createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561439, encodeId=47ee56143954, content=请问这个杂志是月刊还是季刊<span class="quote">183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表:<br>好杂志.效率高</span>, beContent=183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表: 好杂志.效率高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/06/65b1c2edc15a8f02bc91102330953561.jpg, createdBy=c7ab2448888, createdName=灬赫梦灬, createdTime=Tue Sep 25 00:00:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558496, encodeId=85d255849699, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志.效率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6a12344708, createdName=1229ae0cm53(暂无昵称), createdTime=Wed Jun 27 15:09:00 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-11-09 1e105fc2m38(暂无匿称)

    请问需要审稿费吗spanclassquote灬赫梦灬20181006发表br审稿时间约1个月投了一篇文章审稿非常效率3天后就回复了说是文章不在这个期刊的范围内原文TargetedOncologyfocusesonthedevelopmentanduseofmolecularlytargetedagentsinoncologyYourcurrentsubmissionisthereforeoutsidethescopeofthejournal推荐我使用TheSpringerTransferDeskservice推荐给我合适的期刊已同意等待回复期刊列表中我会持续更新最新动态给以后大家的投稿提供经验吧勿喷谢谢span

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=563459, encodeId=6a6e5634592b, content=我的和您一样，他们推荐的杂志都是sci收录的吗<span class="quote">灬赫梦灬 2018-10-06 00:00:00 发表:<br>投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）</span>, beContent=灬赫梦灬 2018-10-06 00:00:00 发表: 投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er3UxGicC980EKc92ndV1cBYEGDyd0wziapVJ0KcPnu0S3QxngVtCgGIt9ehOm7sibVgcKOPIq7tsx6A/132, createdBy=2838104137, createdName=joemarton, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563026, encodeId=777356302671, content=请问需要审稿费吗spanclassquote灬赫梦灬20181006发表br审稿时间约1个月投了一篇文章审稿非常效率3天后就回复了说是文章不在这个期刊的范围内原文TargetedOncologyfocusesonthedevelopmentanduseofmolecularlytargetedagentsinoncologyYourcurrentsubmissionisthereforeoutsidethescopeofthejournal推荐我使用TheSpringerTransferDeskservice推荐给我合适的期刊已同意等待回复期刊列表中我会持续更新最新动态给以后大家的投稿提供经验吧勿喷谢谢span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0e71947222, createdName=1e105fc2m38(暂无匿称), createdTime=Fri Nov 09 22:16:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562475, encodeId=951e5624e547, content=请问需要多少版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed852076992, createdName=Aaaaaaaaa6010, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561560, encodeId=e68056156011, content=季刊<span class="quote">灬赫梦灬 2018-09-25 00:00:00 发表:<br>请问这个杂志是月刊还是季刊</span>, beContent=灬赫梦灬 2018-09-25 00:00:00 发表: 请问这个杂志是月刊还是季刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6a12344708, createdName=1229ae0cm53(暂无昵称), createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561439, encodeId=47ee56143954, content=请问这个杂志是月刊还是季刊<span class="quote">183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表:<br>好杂志.效率高</span>, beContent=183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表: 好杂志.效率高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/06/65b1c2edc15a8f02bc91102330953561.jpg, createdBy=c7ab2448888, createdName=灬赫梦灬, createdTime=Tue Sep 25 00:00:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558496, encodeId=85d255849699, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志.效率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6a12344708, createdName=1229ae0cm53(暂无昵称), createdTime=Wed Jun 27 15:09:00 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-10-29 Aaaaaaaaa6010

    请问需要多少版面费？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=563459, encodeId=6a6e5634592b, content=我的和您一样，他们推荐的杂志都是sci收录的吗<span class="quote">灬赫梦灬 2018-10-06 00:00:00 发表:<br>投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）</span>, beContent=灬赫梦灬 2018-10-06 00:00:00 发表: 投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er3UxGicC980EKc92ndV1cBYEGDyd0wziapVJ0KcPnu0S3QxngVtCgGIt9ehOm7sibVgcKOPIq7tsx6A/132, createdBy=2838104137, createdName=joemarton, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563026, encodeId=777356302671, content=请问需要审稿费吗spanclassquote灬赫梦灬20181006发表br审稿时间约1个月投了一篇文章审稿非常效率3天后就回复了说是文章不在这个期刊的范围内原文TargetedOncologyfocusesonthedevelopmentanduseofmolecularlytargetedagentsinoncologyYourcurrentsubmissionisthereforeoutsidethescopeofthejournal推荐我使用TheSpringerTransferDeskservice推荐给我合适的期刊已同意等待回复期刊列表中我会持续更新最新动态给以后大家的投稿提供经验吧勿喷谢谢span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0e71947222, createdName=1e105fc2m38(暂无匿称), createdTime=Fri Nov 09 22:16:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562475, encodeId=951e5624e547, content=请问需要多少版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed852076992, createdName=Aaaaaaaaa6010, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561560, encodeId=e68056156011, content=季刊<span class="quote">灬赫梦灬 2018-09-25 00:00:00 发表:<br>请问这个杂志是月刊还是季刊</span>, beContent=灬赫梦灬 2018-09-25 00:00:00 发表: 请问这个杂志是月刊还是季刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6a12344708, createdName=1229ae0cm53(暂无昵称), createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561439, encodeId=47ee56143954, content=请问这个杂志是月刊还是季刊<span class="quote">183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表:<br>好杂志.效率高</span>, beContent=183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表: 好杂志.效率高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/06/65b1c2edc15a8f02bc91102330953561.jpg, createdBy=c7ab2448888, createdName=灬赫梦灬, createdTime=Tue Sep 25 00:00:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558496, encodeId=85d255849699, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志.效率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6a12344708, createdName=1229ae0cm53(暂无昵称), createdTime=Wed Jun 27 15:09:00 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-09-28 1229ae0cm53(暂无昵称)

    季刊灬赫梦灬 2018-09-25 00:00:00 发表:
    请问这个杂志是月刊还是季刊

    灬赫梦灬 2018-09-25 00:00:00 发表: 请问这个杂志是月刊还是季刊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=563459, encodeId=6a6e5634592b, content=我的和您一样，他们推荐的杂志都是sci收录的吗<span class="quote">灬赫梦灬 2018-10-06 00:00:00 发表:<br>投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）</span>, beContent=灬赫梦灬 2018-10-06 00:00:00 发表: 投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er3UxGicC980EKc92ndV1cBYEGDyd0wziapVJ0KcPnu0S3QxngVtCgGIt9ehOm7sibVgcKOPIq7tsx6A/132, createdBy=2838104137, createdName=joemarton, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563026, encodeId=777356302671, content=请问需要审稿费吗spanclassquote灬赫梦灬20181006发表br审稿时间约1个月投了一篇文章审稿非常效率3天后就回复了说是文章不在这个期刊的范围内原文TargetedOncologyfocusesonthedevelopmentanduseofmolecularlytargetedagentsinoncologyYourcurrentsubmissionisthereforeoutsidethescopeofthejournal推荐我使用TheSpringerTransferDeskservice推荐给我合适的期刊已同意等待回复期刊列表中我会持续更新最新动态给以后大家的投稿提供经验吧勿喷谢谢span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0e71947222, createdName=1e105fc2m38(暂无匿称), createdTime=Fri Nov 09 22:16:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562475, encodeId=951e5624e547, content=请问需要多少版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed852076992, createdName=Aaaaaaaaa6010, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561560, encodeId=e68056156011, content=季刊<span class="quote">灬赫梦灬 2018-09-25 00:00:00 发表:<br>请问这个杂志是月刊还是季刊</span>, beContent=灬赫梦灬 2018-09-25 00:00:00 发表: 请问这个杂志是月刊还是季刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6a12344708, createdName=1229ae0cm53(暂无昵称), createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561439, encodeId=47ee56143954, content=请问这个杂志是月刊还是季刊<span class="quote">183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表:<br>好杂志.效率高</span>, beContent=183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表: 好杂志.效率高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/06/65b1c2edc15a8f02bc91102330953561.jpg, createdBy=c7ab2448888, createdName=灬赫梦灬, createdTime=Tue Sep 25 00:00:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558496, encodeId=85d255849699, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志.效率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6a12344708, createdName=1229ae0cm53(暂无昵称), createdTime=Wed Jun 27 15:09:00 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-09-25 灬赫梦灬

    请问这个杂志是月刊还是季刊183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表:
    好杂志.效率高

    183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表: 好杂志.效率高

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=563459, encodeId=6a6e5634592b, content=我的和您一样，他们推荐的杂志都是sci收录的吗<span class="quote">灬赫梦灬 2018-10-06 00:00:00 发表:<br>投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）</span>, beContent=灬赫梦灬 2018-10-06 00:00:00 发表: 投了一篇文章，审稿非常效率，3天后就回复了。说是文章不在这个期刊的范围内 (原文："Targeted Oncology focuses on the development and use of molecularly targeted agents in oncology. Your current submission is therefore outside the scope of the journal.")，推荐我使用"The Springer Transfer Desk service"推荐给我合适的期刊，已同意，等待回复期刊列表中。我会持续更新最新动态，给以后大家的投稿提供经验吧，勿喷谢谢。（＾＿＾）, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er3UxGicC980EKc92ndV1cBYEGDyd0wziapVJ0KcPnu0S3QxngVtCgGIt9ehOm7sibVgcKOPIq7tsx6A/132, createdBy=2838104137, createdName=joemarton, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563026, encodeId=777356302671, content=请问需要审稿费吗spanclassquote灬赫梦灬20181006发表br审稿时间约1个月投了一篇文章审稿非常效率3天后就回复了说是文章不在这个期刊的范围内原文TargetedOncologyfocusesonthedevelopmentanduseofmolecularlytargetedagentsinoncologyYourcurrentsubmissionisthereforeoutsidethescopeofthejournal推荐我使用TheSpringerTransferDeskservice推荐给我合适的期刊已同意等待回复期刊列表中我会持续更新最新动态给以后大家的投稿提供经验吧勿喷谢谢span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0e71947222, createdName=1e105fc2m38(暂无匿称), createdTime=Fri Nov 09 22:16:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562475, encodeId=951e5624e547, content=请问需要多少版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed852076992, createdName=Aaaaaaaaa6010, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561560, encodeId=e68056156011, content=季刊<span class="quote">灬赫梦灬 2018-09-25 00:00:00 发表:<br>请问这个杂志是月刊还是季刊</span>, beContent=灬赫梦灬 2018-09-25 00:00:00 发表: 请问这个杂志是月刊还是季刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6a12344708, createdName=1229ae0cm53(暂无昵称), createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561439, encodeId=47ee56143954, content=请问这个杂志是月刊还是季刊<span class="quote">183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表:<br>好杂志.效率高</span>, beContent=183FusB3253(暂无昵称) 2018-06-27 15:09:00 发表: 好杂志.效率高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/06/65b1c2edc15a8f02bc91102330953561.jpg, createdBy=c7ab2448888, createdName=灬赫梦灬, createdTime=Tue Sep 25 00:00:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558496, encodeId=85d255849699, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志.效率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6a12344708, createdName=1229ae0cm53(暂无昵称), createdTime=Wed Jun 27 15:09:00 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-06-27 1229ae0cm53(暂无昵称)

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：好杂志.效率高

    0

共31条页码: 2/4页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分